Samy Suissa
Faculty
Epidemiology, Biostatistics and Occupational Health
McGill University
Canada
Biography
Dr. Samy Suissa (PhD, University of Florida '82) is Director of the Centre for Clinical Epidemiology, Lady Davis Institute, and Professor, Departments of Epidemiology and Biostatistics and of Medicine, McGill University. Dr. Suissa heads the Canadian Network for Observational Drug Effect Studies (CNODES) and the McGill Pharmacoepidemiology Research Unit. He was the founding Director of the Quebec Research Network on Medication Use, funded by the FRSQ. Dr. Suissa has chaired and served on several review committees for the Fonds de la recherche en santé du Québec (FRSQ) and the Canadian Institutes of Health Research (CIHR), including chairing the FRSQ Chercheur-National awards committee. He serves on the External Advisory Board of PROTECT, the drug safety consortium formed by the European Innovative Medicines Initiative (IMI). Dr. Suissa is on the Editorial Board of the European Respiratory Journal, Lancet Respiratory Medicine, COPD -The Journal of Chronic Obstructive Pulmonary Disease, and Pharmacoepidemiology and Drug Safety. He is a Section Head editor in statistical methodologies and health informatics for F-1000 Medicine. He served as Associate Editor of the Journal of Disease Management and Health Outcomes, as well as Treatments in Respiratory Medicine. He was an elected member of the boards of directors of the International Society of Pharmacoepidemiology and of the Canadian Association for Pharmaceutical Therapeutics.
Research Interest
Pharmacoepidemiology
Publications
-
Suissa S, Azoulay L. Metformin and the risk of cancer: time-related biases in observational studies. Diabetes Care 2012;35(12):2665-2673.
-
Suissa S, Ariel A. FDA-mandated trials of LABA safety in asthma: will we know the answer? Chest 2013;143(5):1208-1213.
-
Suissa S, Patenaude V, Lapi F, Ernst P. Inhaled corticosteroids in COPD and the risk of serious pneumonia. Thorax 2013;68(11):1029-36.